Video Walls Market Growing at a CAGR of 14.1% by 2027- Future Market Insights
/
Date12 Mar 2018
VALLEY COTTAGE, NY, March 12, 2018 (GLOBE NEWSWIRE) — Future Market Insights (FMI) has recently published a research report titled “Video Walls Market: Global Industry... Read More →
Salg af aktiebeholdning i ValueInvest Asset Management S.A. i Luxembourg
/
Date12 Mar 2018
Nordfyns Bank har indgået aftale om salg af bankens aktiebeholdning i ValueInvest Asset Management S.A. i Luxembourg i henhold til vedlagte meddelelse. Salget af aktiebeholdningen medfører... Read More →
Hersha Hospitality Trust Announces Quarterly Dividends
/
Date12 Mar 2018
PHILADELPHIA, March 12, 2018 (GLOBE NEWSWIRE) — Hersha Hospitality Trust (NYSE:HT) (“Hersha” or the “Company”), owner of high quality hotels in urban gateway markets and... Read More →
Wave Life Sciences Reports Fourth Quarter and Full-Year 2017 Financial Results and Provides Business Update
/
Date12 Mar 2018
Initiated three clinical trials in 2017 and on track to deliver three additional development programs in 2018 Neurology pipeline growing; candidate in spinocerebellar ataxia type... Read More →
Gladstone Commercial Corporation Announces $14.3 Million Industrial Acquisition in Vance, AL
/
Date12 Mar 2018
MCLEAN, Va., March 12, 2018 (GLOBE NEWSWIRE) — Gladstone Commercial Corporation (NASDAQ:GOOD) (“Gladstone Commercial”) announced today that it completed the acquisition of a 127,444 square... Read More →
CNL Launches Company to Acquire the Debt and Equity of Private U.S. Businesses
/
Date12 Mar 2018
Orlando, Fla., March 07, 2018 (GLOBE NEWSWIRE) — CNL Financial Group (CNL) has launched CNL Strategic Capital, LLC (CNL Strategic Capital), a limited liability company... Read More →
Containership plc’s Financial Statement for 1 January – 31 December 2017
/
Date12 Mar 2018
Containerships plc Financial Statements 12 March 2018, at 9.00 EEST Containership plc’s Financial Statement for 1 January – 31 December 2017 Containerships plc’s full financial... Read More →
Sarepta Therapeutics Announces Plan to Submit a New Drug Application (NDA) for Accelerated Approval of Golodirsen (SRP-4053) in Patients with Duchenne Muscular Dystrophy (DMD) Amenable to Skipping Exon 53
/
Date12 Mar 2018
— The Company met with the FDA Division of Neurology Products in February to obtain guidance on the regulatory pathway for golodirsen — — The... Read More →